课题基金 / 基金详情

Protease-activated receptor (PAR)-2: A novel effector of mucosal healing in inflammatory bowel diseases

Protease-activated receptor (PAR)-2: A novel effector of mucosal healing in inflammatory bowel diseases
蛋白酶激活受体(PAR)-2:炎症性肠病粘膜愈合的新型效应物
批准号:
354779
负责人:
MacNaughton Wallace K
金额:
$72.73万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2016
资助国家:
加拿大
项目状态:
已结题
起止时间:
2016-10-01 至 2021-10-01

项目摘要

项目成果

MacNaughton Wallace K的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis, affect over 200,000 Canadians. These are lifelong, debilitating conditions that have no clear cause, no cure, and which have significant costs to the health care system and pa
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Banff Inflammation Workshop 2023
  • 批准号:
    467997
  • 项目类别:
    Miscellaneous Programs
  • 资助金额:
    $0.73万
  • 财政年份:
    2022
  • 负责人:
    MacNaughton Wallace K
  • 依托单位:
Proteolytically derived peptide fragments of E-cadherin mediate epithelial restitution: a new paradigm for mucosal healing in inflammatory bowel diseases
  • 批准号:
    384147
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2018
  • 负责人:
    MacNaughton Wallace K
  • 依托单位:
Banff Inflammation Workshop 2013
  • 批准号:
    264688
  • 项目类别:
    Miscellaneous Programs
  • 资助金额:
    $1.82万
  • 财政年份:
    2012
  • 负责人:
    MacNaughton Wallace K
  • 依托单位:
Regulation of intestinal epithelial permeability by serine proteases
  • 批准号:
    237182
  • 项目类别:
    Operating Grants
  • 资助金额:
    $41.72万
  • 财政年份:
    2011
  • 负责人:
    MacNaughton Wallace K
  • 依托单位:
海外基金